KMC SPECIALITY HOSPITALS (INDIA) LTD.

KMC Speciality Hospitals (India) Ltd has announced that its Board of Directors will convene on November 13, 2026. The primary agenda item for this meeting is to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026. This meeting is being held in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

KMC Speciality Hospitals (India) Ltd has submitted revised disclosures under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. These revisions address discrepancies identified by BSE regarding encumbered shareholdings and lender details in prior submissions dated September 15, 2026. The holding company, Sri Kauvery Medical Care (India) Limited, rectified issues related to pre-event encumbered shareholdings and provided complete lender information for transactions on August 4, 2026, and September 4, 2026. The company is complying with regulatory directions to ensure accurate reporting.

KMC Speciality Hospitals (India) Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's code of conduct. The window will be shut from October 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter and half-year ending September 30, 2026. This measure is to prevent potential insider trading during the period leading up to the financial results announcement.

KMC Speciality Hospitals (India) Ltd has submitted a revised disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, following discrepancies identified by BSE. The revisions address specific transaction dates for encumbrances, reasons for encumbrance, and the inclusion of both lender and trustee names. The company, through its holding company Sri Kauvery Medical Care (India) Limited, has aligned its disclosures with the updated SEBI circular format effective August 5, 2015. This action rectifies issues related to pre-event and post-event encumbered shareholdings and ensures compliance with regulatory requirements.

Sri Kauvery Medical Care (India) Limited, a promoter of KMC Speciality Hospitals (India) Limited, has disclosed the creation of an indirect encumbrance over 27,41,435 equity shares, representing 5.37% of the fully diluted shareholding. This encumbrance, created on September 4, 2026, is in the form of a pledge over shares of SKMCIL in favor of Catalyst Trusteeship Limited, acting as Debenture Trustee. The pledge serves as security for non-convertible debentures to be issued by Prospera Healthcorp Private Limited. This disclosure is made in compliance with SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

KMC Speciality Hospitals (India) Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26. The report, which is part of the Annual Report, details the company's corporate identity, business activities primarily in hospital and medical care services (100% of turnover), operational locations, employee turnover rates, and its holding company, Sri Kauvery Medical Care (India) Limited. It also confirms CSR applicability with a turnover of ₹305.77 Cr and net worth of ₹210.43 Cr, and notes the absence of complaints filed by community stakeholders.

KMC Speciality Hospitals (India) Ltd has announced its 43rd Annual General Meeting (AGM) scheduled for September 28, 2026, to be held via Video Conference (VC) / Other Audio Visual Means (OAVM). The company has engaged CDSL for e-voting services. The Annual Report for FY 2025-26, along with the AGM notice, has been sent to shareholders and is available on the company's website. Key financial highlights for FY 2025-26 include Revenue from Operations of ₹305.8 Cr, EBITDA of ₹93 Cr, and PAT of ₹46.73 Cr. The company also reported a hospital capacity of 450 beds, over 170 doctors, and 1695 employees.

KMC Speciality Hospitals (India) Ltd has announced the details for its 43rd Annual General Meeting (AGM), scheduled for September 28, 2026, at 10:30 AM IST. The meeting will be conducted via Video Conference (VC) / Other Audio Visual Means (OAVM), with e-voting services provided by CDSL. Key agenda items include the adoption of audited financial statements for FY26, the appointment of a director, and approval for material related party transactions with its holding company, Sri Kauvery Medical Care (India) Limited, up to ₹65 crore for FY27. The cut-off date for voting on AGM resolutions is September 21, 2026, with e-voting commencing on September 25 and ending on September 27, 2026.

KMC Speciality Hospitals (India) Ltd announced board approval for significant capacity expansion projects in Trichy and Bengaluru. The Trichy campus expansion includes adding four floors to the Mother & Child Care Hospital and constructing a new Super-Speciality Block, aiming to add approximately 500 beds at a cost of ₹486 crores. The Bengaluru project involves a dedicated Mother & Child Hospital on leased premises, adding around 91 beds for ₹33 crores. The company also appointed M/s. G Sugumar & Co as its Cost Auditor for FY 2026-27. The Trichy expansion is planned in two phases, with commissioning expected in Q4 FY'28 and Q2 FY'30, while the Bengaluru unit is slated for Q2 FY'28.

KMC Speciality Hospitals (India) Ltd announced its standalone unaudited financial results for the quarter ended June 30, 2026. The results were approved by the Board of Directors at a meeting held on August 14, 2026. The company submitted these results along with the Limited Review Report from its statutory auditors, Deloitte Haskins & Sells. The financial statements have been prepared in accordance with Indian Accounting Standard 34 and comply with SEBI Listing Regulations.